Evaluation of Right Ventricular Myocardial Work in Patients With Pulmonary Arterial Hypertension

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Right ventricular function is a key determinant of survival in patients with pulmonary arterial hypertension, with right heart failure being the leading cause of death. ERS/ESC guidelines recommend evaluating RV function at diagnosis and at first reevaluation under treatment to estimate the one-year mortality risk. However, few RV function markers address both systolic function and afterload. Noninvasive myocardial work is a promising new tool that incorporates systolic function and its afterload into global longitudinal strain. Initially developed for the left ventricle, it can be adapted for the RV using pressure-strain loops. The article aims to evaluate the association of RV myocardial work parameters with the estimate one-year mortality in patients with PAH. This retrospective study will include patients diagnosed with PAH with transthoracic echocardiography and right heart catheterization within 48 hours at diagnosis and first reevaluation. Patients with unanalyzable echocardiography data will be excluded.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
View:

• All consecutive incident patients with a diagnosis of idiopathic, heritable, drug-associated PH, or associated with portal hypertension and referred to PH reference center in Nancy university hospital.

• Transthoracic echocardiography (TTE) and a right heart catheterization (RHC) within 48 hours at diagnosis and at first reevaluation with PAH treatment

Locations
Other Locations
France
Valentin
RECRUITING
Nancy
Contact Information
Primary
Simon Valentin, M.D.
s.valentin@chru-nancy.fr
+33383153405
Time Frame
Start Date: 2024-07-25
Estimated Completion Date: 2024-09-30
Participants
Target number of participants: 30
Treatments
PAH patients
Patients with heritable, idiopathic PAH or PAH associated with portal hypertension or with drugs.
Related Therapeutic Areas
Sponsors
Leads: Central Hospital, Nancy, France

This content was sourced from clinicaltrials.gov